EP3478719
Notkun and-sklerostín mótefna í meðferð á beinbrotasýki
Status:
EP einkaleyfi: Endurútgefin þýðing EP einkaleyfisEP appl. date:
21.12.2017EP published:
20.1.2021EP application number:
17823190.8
EP translation filed:
25.2.2021Grant published:
15.3.2021EPO information:
European Patent Register
Max expiry date:
20.12.2037Expiry date:
20.12.2026Next due date:
31.12.2026
Title:
USE OF ANTI-SCLEROSTIN ANTIBODIES IN THE TREATMENT OF OSTEOGENESIS IMPERFECTA
Timeline
Today
21.12.2017EP application
20.1.2021EP Publication
25.2.2021Translation submitted
15.3.2021Registration published
20.12.2026Expires
Owner
Name:
Mereo Biopharma 3 LimitedAddress:
4th Floor 1 Cavendish Place, London W1G 0QF, GB
Inventor
Name:
JUNKER, UweAddress:
4070 Basel, CH
Name:
KNEISSEL, MichaelaAddress:
4002 Basel, CH
Name:
HALL, Anthony KentAddress:
2341 JB Oegstgeest, NL
Name:
EUDY, Rena JoyAddress:
West Hartford Connecticut 06117, US
Name:
RIGGS, Matthew ManningAddress:
Haddam Connecticut 06438, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201662437353 PDate:
21.12.2016Country:
US
Classification
Categories:
C07K 16/22, A61K 39/395, A61P 19/08, A61K 39/00
Annual fees
Number
Paid
Expires
Payer
Number: 5
Paid: 8.11.2021
Expires: 20.12.2022
Payer: Árnason Faktor ehf.
Number: 6
Paid: 9.11.2022
Expires: 20.12.2023
Payer: Árnason Faktor ehf.
Number: 7
Paid: 11.12.2023
Expires: 20.12.2024
Payer: Árnason Faktor ehf.
Number: 8
Paid: 5.11.2024
Expires: 20.12.2025
Payer: Árnason Faktor ehf.
Number: 9
Paid: 17.12.2025
Expires: 20.12.2026
Payer: Árnason Faktor ehf.